Filing Details

Accession Number:
0001209191-21-035364
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-24 16:52:50
Reporting Period:
2021-05-20
Accepted Time:
2021-05-24 16:52:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1699382 Pmv Pharmaceuticals Inc. PMVP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341642 Henry David Mack C/O Pmv Pharmaceuticals, Inc.
8 Clarke Drive, Suite 3
Cranbury NJ 08512
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-20 7,793 $0.53 10,263 No 4 M Direct
Common Stock Disposition 2021-05-20 7,793 $35.60 2,470 No 4 S Direct
Common Stock Acquisiton 2021-05-21 6,207 $0.53 8,677 No 4 M Direct
Common Stock Disposition 2021-05-21 6,207 $35.71 2,470 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-05-20 7,793 $0.00 7,793 $0.53
Common Stock Stock Option (right to buy) Disposition 2021-05-21 6,207 $0.00 6,207 $0.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
492,867 2025-05-11 No 4 M Direct
485,074 2025-05-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 227,915 Indirect See footnote
Common Stock 56,978 Indirect See footnote
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive.
  4. The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
  5. The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
  6. The shares subject to the option are fully vested and immediately exercisable.